These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 32912310)
1. The feasibility of Liu S; Xia L; Yang Z; Ge H; Wang C; Pan H; Song S; Zhou Z Cancer Imaging; 2020 Sep; 20(1):63. PubMed ID: 32912310 [TBL] [Abstract][Full Text] [Related]
2. The predictive recurrence value of MTV-s as an 18F-FDG PET/CT index in patients with IIB-IVA cervical cancer. Deng C; Ding D; Wang M Postgrad Med; 2021 May; 133(4):436-443. PubMed ID: 33620285 [No Abstract] [Full Text] [Related]
3. Value of [ Li K; Sun H; Lu Z; Xin J; Zhang L; Guo Y; Guo Q Eur J Radiol; 2018 Sep; 106():160-166. PubMed ID: 30150039 [TBL] [Abstract][Full Text] [Related]
4. Prognostic Value of the Sum of Metabolic Tumor Volume of Primary Tumor and Lymph Nodes Using 18F-FDG PET/CT in Patients With Cervical Cancer. Hong JH; Min KJ; Lee JK; So KA; Jung US; Kim S; Eo JS Medicine (Baltimore); 2016 Mar; 95(9):e2992. PubMed ID: 26945420 [TBL] [Abstract][Full Text] [Related]
5. Prognostic importance of lymph node-to-primary tumor standardized uptake value ratio in invasive squamous cell carcinoma of uterine cervix. Chung HH; Cheon GJ; Kim JW; Park NH; Song YS Eur J Nucl Med Mol Imaging; 2017 Oct; 44(11):1862-1869. PubMed ID: 28534183 [TBL] [Abstract][Full Text] [Related]
6. Combinative evaluation of primary tumor and lymph nodes in predicting pelvic lymphatic metastasis in early-stage cervical cancer: A multiparametric PET-CT study. Li K; Sun H; Guo Q Eur J Radiol; 2019 Apr; 113():153-157. PubMed ID: 30927941 [TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of volume-based metabolic parameters in uterine cervical cancer determined using 18F-fluorodeoxyglucose positron emission tomography. Yoo J; Choi JY; Moon SH; Bae DS; Park SB; Choe YS; Lee KH; Kim BT Int J Gynecol Cancer; 2012 Sep; 22(7):1226-33. PubMed ID: 22810970 [TBL] [Abstract][Full Text] [Related]
8. Tumour and pelvic lymph node metabolic activity on FDG-PET/CT to stratify patients for para-aortic surgical staging in locally advanced cervical cancer. Martinez A; Voglimacci M; Lusque A; Ducassou A; Gladieff L; Dupuis N; Angeles MA; Martinez C; Tanguy Le Gac Y; Chantalat E; Hitzel A; Courbon F; Ferron G; Gabiache E Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1252-1260. PubMed ID: 31915897 [TBL] [Abstract][Full Text] [Related]
9. Prognostic value of preoperative intratumoral FDG uptake heterogeneity in early stage uterine cervical cancer. Chung HH; Kang SY; Ha S; Kim JW; Park NH; Song YS; Cheon GJ J Gynecol Oncol; 2016 Mar; 27(2):e15. PubMed ID: 26768781 [TBL] [Abstract][Full Text] [Related]
10. Utility of Volumetric Metabolic Parameters on Preoperative FDG PET/CT for Predicting Tumor Lymphovascular Invasion in Non-Small Cell Lung Cancer. Li C; Tian Y; Shen Y; Wen B; He Y AJR Am J Roentgenol; 2021 Dec; 217(6):1433-1443. PubMed ID: 33978465 [No Abstract] [Full Text] [Related]
11. Impact of tumor histology on detection of pelvic and para-aortic nodal metastasis with Lin AJ; Wright JD; Dehdashti F; Siegel BA; Markovina S; Schwarz J; Thaker PH; Mutch DG; Powell MA; Grigsby PW Int J Gynecol Cancer; 2019 Nov; 29(9):1351-1354. PubMed ID: 31473660 [TBL] [Abstract][Full Text] [Related]
13. 18F-FDG PET/CT can predict nodal metastases but not recurrence in early stage uterine cervical cancer. Crivellaro C; Signorelli M; Guerra L; De Ponti E; Buda A; Dolci C; Pirovano C; Todde S; Fruscio R; Messa C Gynecol Oncol; 2012 Oct; 127(1):131-5. PubMed ID: 22772064 [TBL] [Abstract][Full Text] [Related]
14. Prediction of cervical metastasis and survival in cN0 oral cavity cancer using tumour Bae MR; Roh JL; Kim JS; Choi SH; Nam SY; Kim SY J Cancer Res Clin Oncol; 2020 Dec; 146(12):3341-3348. PubMed ID: 32642973 [TBL] [Abstract][Full Text] [Related]
15. Preoperative PET/CT FDG standardized uptake value of pelvic lymph nodes as a significant prognostic factor in patients with uterine cervical cancer. Chung HH; Cheon GJ; Kang KW; Kim JW; Park NH; Song YS Eur J Nucl Med Mol Imaging; 2014 Apr; 41(4):674-81. PubMed ID: 24233005 [TBL] [Abstract][Full Text] [Related]
16. Preoperative 18F-Fluorodeoxyglucose Positron Emission Tomography/CT in Prediction of Uterine Risk Factors and Lymph Node Metastasis: An Analysis of 111 Endometrioid Endometrial Cancer Patients. Konuralp Atakul B; Taşkın S; Soydal Ç; Sükür YE; Kahraman A; Koyuncu K; İbiş E; Ortac F Gynecol Obstet Invest; 2017; 82(4):340-348. PubMed ID: 27771729 [TBL] [Abstract][Full Text] [Related]
17. Relationship of 18F-FDG PET/CT metabolic, clinical and pathological characteristics of primary squamous cell carcinoma of the cervix. Xu W; Yu S; Xin J; Guo Q J Investig Med; 2016 Dec; 64(8):1246-1251. PubMed ID: 27436350 [TBL] [Abstract][Full Text] [Related]
18. Prognostic value of metabolic tumor volume and total lesion glycolysis from ¹⁸F-FDG PET/CT in lymph node metastases and risk stratification of endometrial carcinoma. Liu DD; Li J; Li X; Xie L; Qin L; Peng F; Cheng MH J Gynecol Oncol; 2019 Nov; 30(6):e89. PubMed ID: 31576685 [TBL] [Abstract][Full Text] [Related]
19. Mantziari S; Pomoni A; Prior JO; Winiker M; Allemann P; Demartines N; Schäfer M BMC Med Imaging; 2020 Jan; 20(1):7. PubMed ID: 31969127 [TBL] [Abstract][Full Text] [Related]
20. Volume-based metabolic parameter of breast cancer on preoperative 18F-FDG PET/CT could predict axillary lymph node metastasis. An YS; Kang DK; Jung Y; Kim TH Medicine (Baltimore); 2017 Nov; 96(45):e8557. PubMed ID: 29137072 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]